"10.1371_journal.ppat.1003264","plos pathogens","2013-04-04T00:00:00Z","Pádraig J Ross; Caroline E Sutton; Sarah Higgins; Aideen C Allen; Kevin Walsh; Alicja Misiak; Ed C Lavelle; Rachel M McLoughlin; Kingston H G Mills","Immune Regulation Research Group, School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin, Ireland; Adjuvant Research Group, School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin, Ireland; Host Pathogen Interactions Group, School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin, Ireland","Conceived and designed the experiments: PJR CES SH KW KHGM. Performed the experiments: PJR CES SH KW AM ACA. Analyzed the data: PJR CES SH KW ECL ACA RMM KHGM. Contributed reagents/materials/analysis tools: ECL RMM. Wrote the paper: PJR CES KHGM.","Kingston Mills a co-founder and shareholder in Opsona Therapeutics and TriMod Therapeutics, start-up companies involved in the development of immunotherapeutics. This does not alter our adherence to all Plos Pathogens policies on sharing data and materials. No other author has a competing interest.","2013","04","Pádraig J Ross","PJR",9,TRUE,5,6,8,3,TRUE,TRUE,FALSE,0,NA,FALSE
